-

ALIGNMENT HEALTHCARE, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ:ALHC). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

[LEARN MORE ABOUT THE INVESTIGATION]

What Happened?

On July 8, 2026, it was reported that a former executive at Alignment Healthcare filed a whistleblower lawsuit alleging that the Company manipulated its finances to boost its stock price and executive compensation.

The whistleblower, who was employed by Alignment from 2019 to 2025 and most recently served as the Company’s chief transformation officer, alleges that Alignment Healthcare misclassified operating expenses as capital expenditures. These actions purportedly boosted the Company’s adjusted EBITDA for 2024 and 2025, thereby artificially inflating key performance metrics tied to both the Company’s stock price and executive compensation. On this news, the price of Alignment Healthcare shares declined by $4.02 per share, or approximately 17%, from $24.05 per share on July 7, 2026 to close at $20.03 on July 8, 2026.

What Should I Do?

At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.

If you purchased or otherwise acquired Alignment Healthcare securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP

NASDAQ:ALHC

Release Versions

Contacts

More News From Kirby McInerney LLP

Securities Class Action Filed Against Compass, Inc. On Behalf of Former Anywhere Real Estate Inc. Investors – Contact Kirby McInerney LLP If You Acquired COMP Shares in Exchange for Your HOUS Securities 

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of former Anywhere Real Estate Inc. (“Anywhere”) (formerly trading as NYSE: HOUS) investors who acquired Compass, Inc. (“Compass” or the “Company”) (NYSE: COMP) common stock in direct exchange for Anywhere securities pursuant to the S-4 registration statement, 424B3 prospectus, and related oral communications (collectively, with materials incorporated therein, the “Regist...

Securities Class Action Filed Against Duolingo, Inc. – DUOL Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Duolingo, Inc. (“Duolingo” or the “Company”) (NASDAQ: DUOL) securities between May 2, 2025 and February 26, 2026, inclusive (“the Class Period”). If you suffered a loss on your Duolingo investments, you have until December 7, 2026 to request lead plaintiff appointment.[CONTACT THE FIRM IF YOU SUFFERED A LOSS]Investors are encouraged to fill out t...

Kirby McInerney LLP Alerts Investors Who Acquired Beta Bionics, Inc. BBNX Securities Between July 30, 2025 and February 24, 2026 of Pending Lawsuit

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) investors of the November 3, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.[CONTACT THE...
Back to Newsroom